Molecular Formula | C18H25NO6 |
Molar Mass | 351.39 |
Density | 1.32±0.1 g/cm3 (20 ºC 760 Torr) |
Melting Point | 208-211 °C (lit.) |
Boling Point | 485.2°C (rough estimate) |
Specific Rotation(α) | D18 -17.6° (c = 1.99 in ethanol) |
Appearance | neat |
Merck | 13,8253 |
pKa | 12.00±0.40(Predicted) |
Storage Condition | 2-8°C |
Refractive Index | 1.5100 (estimate) |
Hazard Symbols | T - Toxic |
Risk Codes | 25 - Toxic if swallowed |
Safety Description | S22 - Do not breathe dust. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | 1544 |
WGK Germany | 3 |
RTECS | VH7525000 |
Hazard Class | 6.1(a) |
Packing Group | II |
(IARC) carcinogen classification | 3 (Vol. 10, Sup 7) 1987 |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
biological activity | Retrorsine is a naturally occurring toxic pyrrolidine alkaloid. Retrorsine can bind to DNA and inhibit the proliferation of liver cells. Retrorsine can be used in the study of hepatocyte injury. |
Cell Line: | HSEC-CYP3A4 cells |
Concentration: | 60 μM, 120 μM , 240 μM |
Incubation Time: | 24 hours |
Result: | Significantly decreased cell viability. Strongly impaired the liver weight gain, protein and DNA synthesis as well as induction of cell cycle related proteins in the regenerating lobes after PBL. |
Animal Model: | Male Wistar rats (180±20 g), portal branch ligation (PBL) model |
Dosage: | 30 mg/kg |
Administration: | Intraperitoneal injection, twice, separated by 2-week interval |
toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |